In the published article, there was an error in Table 1. We mistakenly labeled the reference by Sizova et al. (2016) as Russia. It should be corrected to Ukraine. The corrected Table 1 and its caption appear below.
Table 1.
Characteristics of studies involved in the meta-analysis.
| Study | Country | Controls | Sample size* | Distribution of genotype and allele | Genotyping method | PHWE | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| rs3775290(TLR3) | CC | CT | TT | C | T | |||||
| Mosaad et al. (2018) | Egypt | Healthy individuals | 100/100 | 6/37 | 90/50 | 4/13 | 102/124 | 98/76 | PCR-RFLP | 0.541 |
| Abdelwahab et al. (2020) | Egypt | Seronegative health-care workers | 70/159 | 46/105 | 18/46 | 6/8 | 110/256 | 30/62 | PCR-RFLP | 0.323 |
| Sghaier et al. (2018) | Tunisia | Seronegative individuals | 174/360 | 77/157 | 51/149 | 46/54 | 205/463 | 143/257 | PCR-RFLP | 0.062 |
| Hamdy et al. (2018) | Egypt | Seronegative health-care workers | 235/284 | 141/170 | 78/95 | 16/19 | 360/435 | 110/133 | PCR-RFLP | 0.257 |
| Zayed et al. (2017) | Egypt | Healthy individuals | 100/100 | 66/55 | 28/39 | 6/6 | 160/149 | 40/51 | PCR-RFLP | 0.791 |
| Chi et al. (2017) | China | Healthy individuals | 122/42 | 37/12 | 41/16 | 44/14 | 115/40 | 129/44 | SNPscanTM Multiplex SNP Typing Kit | 0.126 |
| rs179008(TLR7) | AA | AT | TT | A | T | |||||
| Mosaad et al. (2018) | Egypt | Healthy individuals | 30/30 | 13/11 | 10/14 | 7/5 | 144/138 | 56/62 | PCR-RFLP | 0.880 |
| Fakhir et al. (2017) | Morocco | Individuals without liver diseases | 246/72 | 85/33 | 83/27 | 78/12 | 312/133 | 346/77 | TaqMan allelic discrimination assays, PCR-RFLP | 0.123 |
| Valverde-Villegas et al. (2017) | Brazil (European descendants) | HIV-infected individuals | 16/81 | 10/57 | 6/24 | 22/64 | 2/13 | PCR-RFLP | 0.802 | |
| Brazil (African descendants) | HIV-infected individuals | 19/45 | 12/33 | 7/12 | 32/43 | 6/13 | PCR-RFLP | 0.050 | ||
| Malov et al. (2018) | Russia | Healthy individuals | 120/132 | 99/119 | 15/10 | 6/3 | 213/248 | 27/16 | AmpliSense-HCV-genotype kit, real-time PCR | 0.000 |
| Sizova et al. (2016) | Ukraine | Healthy individuals | 125/85 | 102/63 | 21/19 | 2/3 | 225/145 | 25/25 | PCR-RFLP | 0.460 |
HCV group/control group; PCR-RFLP, PCR-restriction fragment length polymorphism; some PHWE values were obtained directly from the original text of the study, the investigator calculated it and retained three decimal places when there was no information of PHWE value in the original text, PHWE < 0.05 indicates that it does not conform to Hardy-Weinberg equilibrium; The TLR7 rs179008 gene polymorphism occurs on the X chromosome, so only the female population is used as study objects in principle when counting the genotype distribution; In Valverde-Villegas et al. (2017) studies, the sample size of genotype AT and TT only showed the sum of these two because the data provided in the original article was not detailed.
In the published article, there was an error. The selected studies used for our meta-analysis contain populations from seven countries, instead of six countries.
A correction has been made to Results, Study characteristics and quality assessment results, Paragraph 1. This sentence previously stated:
“The selected studies contain populations from six countries, covering many regions, such as Africa, Europe, and Asia.”
The corrected sentence appears below:
“The selected studies contain populations from seven countries, covering many regions, such as Africa, Europe, and Asia.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
- Abdelwahab S. F., Hamdy S., Osman A. M., Zakaria Z. A., Galal I., Sobhy M., et al. (2020). Association of the polymorphism of the Toll-like receptor (TLR)-3 and TLR-9 genes with hepatitis C virus-specific cell-mediated immunity outcomes among Egyptian health-care workers. Clin. Exp. Immunol. 203, 3–12. 10.1111/cei.13514 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chi X.-W., Liu J., Zhang L., Zhang Y., Chen H., Wang H., et al. (2017). Relationship between TLR3 polymorphisms and disease progression in patients with chronic HCV infection combined with HIV infection. Chin. J. Integr. Tradit. West. Med. Dig. 25, 965–969. 10.3969/j.issn.1671-038X.2017.12.17 [DOI] [Google Scholar]
- Fakhir F.-Z., Lkhider M., Badre W., Alaoui R., Meurs E. F., Pineau P., et al. (2017). Genetic variations in toll-like receptors 7 and 8 modulate natural hepatitis C outcomes and liver disease progression. Liver Int. 38, 432–442. 10.1111/liv.13533 [DOI] [PubMed] [Google Scholar]
- Hamdy S., Osman A. M., Zakaria Z. A., Galal I., Sobhy M., Hashem M., et al. (2018). Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians. Arch. Virol. 163, 2433–2442. 10.1007/s00705-018-3893-8 [DOI] [PubMed] [Google Scholar]
- Malov S. I., Baatarkhuu O., Ogarkov O. B., Ariunaa S., Baigalmaa J., Davaakhuu B., et al. (2018). The role of human genetic factors in the natural selection of hepatitis C virus' dominant genotype in ethnically close populations of Buryats and Khalkha-Mongols. Sovrem. Tehnol. Med. 10, 21. 10.17691/stm2018.10.3.3 [DOI] [Google Scholar]
- Mosaad Y. M., Metwally S. S., Farag R. E., Lotfy Z. F., AbdelTwab H. E. (2018). Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV. Immunol. Investig. 48, 321–332. 10.1080/08820139.2018.1527851 [DOI] [PubMed] [Google Scholar]
- Sghaier I., Zidi S., Mouelhi L., Ghazoueni E., Brochot E., Almawi W., et al. (2018). TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection. Br. J. Biomed. Sci. 76, 35–41. 10.1080/09674845.2018.1547179 [DOI] [PubMed] [Google Scholar]
- Sizova L., Koval T., Kaidashev I., Ilchenko V., Dubinskaya G. (2016). The role of genetic polymorphisms toll-like receptor 4 and 7 in the chronic hepatitis c and gender features of their distribution. Georgian. Med. News 250, 51–56. [PubMed] [Google Scholar]
- Valverde-Villegas J. M., Dos Santos B. P., de Medeiros R. M., Mattevi V. S., Lazzaretti R. K., Sprinz E., et al. (2017). Endosomal toll-like receptor gene polymorphisms and susceptibility to HIV and HCV co-infection - differential influence in individuals with distinct ethnic background. Hum. Immunol. 78, 221–226. 10.1016/j.humimm.2017.01.001 [DOI] [PubMed] [Google Scholar]
- Zayed R. A., Omran D., Mokhtar D. A., Zakaria Z., Ezzat S., Soliman M. A., et al. (2017). Association of toll-like receptor 3 and toll-like receptor 9 single nucleotide polymorphisms with hepatitis C virus infection and hepatic fibrosis in Egyptian patients. Am. J. Trop. Med. Hyg. 16, 0644. 10.4269/ajtmh.16-0644 [DOI] [PMC free article] [PubMed] [Google Scholar]
